Anti-tumor immunity and ferroptosis of hepatocellular carcinoma are enhanced by combined therapy of sorafenib and delivering modified GO-based PD-L1 siRNAs
- Resource Type
- Article
- Source
- In
Biomaterials Advances May 2022 136 - Subject
- Language
- ISSN
- 2772-9508